A citation-based method for searching scientific literature

Alaa Abdelatty, Dan Fang, Guanqun Wei, Fubing Wu, Chengfei Zhang, Haojun Xu, Chengyun Yao, Yundong Wang, Hongping Xia. Pathobiology 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Predicting 3D Structure, Cross Talks, and Prognostic Significance of KLF9 in Cervical Cancer.
Sadia Safi, Yasmin Badshah, Maria Shabbir, Kainat Zahra, Khushbukhat Khan, Erum Dilshad, Tayyaba Afsar, Ali Almajwal, Nawaf W Alruwaili, Dara Al-Disi,[...]. Front Oncol 2022
3
100

Protein kinase Cα protects against multidrug resistance in human colon cancer cells.
Se-Kyoung Lee, Adeeb Shehzad, Jae-Chang Jung, Jong-Kyung Sonn, Jae-Tae Lee, Jeen-Woo Park, Young-Sup Lee. Mol Cells 2012
27
100

PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.
Sheng Yao, Alix Bee, Daniel Brewer, Andrew Dodson, Carol Beesley, Youqiang Ke, Laurence Ambroisine, Gabrielle Fisher, Heinrich Møller, Tim Dickinson,[...]. Genes Cancer 2010
38
100


Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression.
R Engers, S Mrzyk, E Springer, D Fabbro, G Weissgerber, C D Gernharz, H E Gabbert. Br J Cancer 2000
46
100

Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation.
Yan Ling, Luo Chunli, Wu Xiaohou, Zhang Qiaoling. Cell Biol Int 2011
23
100

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
Pei-Chih Lee, Yueh-Fu Fang, Hirohito Yamaguchi, Wei-Jan Wang, Tse-Ching Chen, Xuan Hong, Baozhen Ke, Weiya Xia, Yongkun Wei, Zhengyu Zha,[...]. Cancer Cell 2018
45
100

Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo.
Zhihong Chen, Lora W Forman, Robert M Williams, Douglas V Faller. BMC Cancer 2014
38
100

Atypical Protein Kinase C λ/ι Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma.
Junichi Baba, Mitomu Kioi, Kazunori Akimoto, Yoji Nagashima, Masataka Taguri, Yoshiaki Inayama, Ichiro Aoki, Shigeo Ohno, Kenji Mitsudo, Iwai Tohnai. Anticancer Res 2018
4
100

PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo.
Jean-Philip Truman, Susan A Rotenberg, Ji-Hye Kang, Gabriel Lerman, Zvi Fuks, Richard Kolesnick, Victor E Marquez, Adriana Haimovitz-Friedman. Cancer Biol Ther 2009
19
100

N-benzyladriamycin-14-valerate (AD198) induces apoptosis through protein kinase C-delta-induced phosphorylation of phospholipid scramblase 3.
Yongwen He, Jihua Liu, David Durrant, Hung-Sheng Yang, Trevor Sweatman, Leonard Lothstein, Ray M Lee. Cancer Res 2005
19
100

Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.
Jin Cheng, Ling Tian, Jingjing Ma, Yanping Gong, Zhengxiang Zhang, Zhiwei Chen, Bing Xu, Hui Xiong, Chuanyuan Li, Qian Huang. Mol Oncol 2015
53
100

Moracin D induces apoptosis in prostate cancer cells via activation of PPAR gamma/PKC delta and inhibition of PKC alpha.
Jae Seok Yoon, Hyo-Jung Lee, Deok Yong Sim, Eunji Im, Ji Eon Park, Woon Yi Park, Ja Il Koo, Bum Sang Shim, Sung-Hoon Kim. Phytother Res 2021
2
100

PKC-δ attenuates the cancer stem cell among squamous cell carcinoma cells through down-regulating p63.
Dongmei Zhang, Mingjing Fu, Lingyan Li, Huan Ye, Zhiqi Song, Yongjun Piao. Pathol Res Pract 2017
8
100

Topography of Protein Kinase C βII in Benign and Malignant Melanocytic Lesions.
Konstanin Krasagakis, Eleftheria Tsentelierou, Gregory Chlouverakis, Efstathios N Stathopoulos. Int J Surg Pathol 2017
2
100

The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells.
Andrea N McCray, Shraddha Desai, Mildred Acevedo-Duncan. Neurochem Res 2014
5
100

14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
Yan Yang, Yan Liu, Jun-Chuang He, Jian-Ming Wang, Peter Schemmer, Chao-Qun Ma, Ya-Wei Qian, Wei Yao, Jian Zhang, Wei-Peng Qi,[...]. Oncotarget 2016
18
100

PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells.
Bulent Ozpolat, Ugur Akar, Ibrahim Tekedereli, S Neslihan Alpay, Magaly Barria, Baki Gezgen, Nianxiang Zhang, Kevin Coombes, Steve Kornblau, Gabriel Lopez-Berestein. Leuk Res Treatment 2012
6
100

E2F1 transactivates IQGAP3 and promotes proliferation of hepatocellular carcinoma cells through IQGAP3-mediated PKC-alpha activation.
Min Lin, Yiming Liu, Xiaokun Ding, Qinjian Ke, Jieyao Shi, Zewei Ma, Hongqian Gu, Haixi Wang, Chuanfeng Zhang, Chenxi Yang,[...]. Am J Cancer Res 2019
18
100

Impact of PKCε downregulation on autophagy in glioblastoma cells.
Ewa Toton, Aleksandra Romaniuk, Natalia Konieczna, Johann Hofmann, Jan Barciszewski, Maria Rybczynska. BMC Cancer 2018
10
100


Renal cell carcinoma.
Paul Cairns. Cancer Biomark 2010
288
100

Expression of protein kinase C family in human hepatocellular carcinoma.
Hsiu-Chin Lu, Fen-Pi Chou, Kun-Tu Yeh, Ya-Sian Chang, Nicholas C Hsu, Jan-Gowth Chang. Pathol Oncol Res 2010
6
100

VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
Amalia Vartanian, Eugenia Stepanova, Irina Grigorieva, Elico Solomko, Anatoly Baryshnikov, Mikhail Lichinitser. Melanoma Res 2011
54
100


Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions.
Fernando Benavides, Jorge Blando, Carlos J Perez, Rachana Garg, Claudio J Conti, John DiGiovanni, Marcelo G Kazanietz. Cell Cycle 2011
43
100

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Wing C Chan, Patricia Aoun, Gregory T Cochran, Zenggang Pan, Lynette M Smith, James C Lynch, Robert Gregory Bociek,[...]. Mod Pathol 2005
99
100

Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population.
Qiaoxin Li, Chengyuan Gu, Yao Zhu, Mengyun Wang, Yajun Yang, Jiucun Wang, Li Jin, Mei-Ling Zhu, Ting-Yan Shi, Jing He,[...]. Mol Carcinog 2015
3
100

Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab.
Kritika Chaiwatanatorn, Georgia Stamaratis, Ken Opeskin, Frank Firkin, Harshal Nandurkar. Leuk Lymphoma 2009
14
100

Heterogeneity of protein kinase C beta(2) expression in lymphoid malignancies.
A-V Decouvelaere, F Morschhauser, D Buob, M C Copin, C Dumontet. Histopathology 2007
15
100

A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Amanda M Butler, Michele L Scotti Buzhardt, Eda Erdogan, Shuhua Li, Kristin S Inman, Alan P Fields, Nicole R Murray. Oncotarget 2015
31
100

Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
C Meyer zum Büschenfelde, M Wagner, G Lutzny, M Oelsner, Y Feuerstacke, T Decker, C Bogner, C Peschel, I Ringshausen. Leukemia 2010
34
100

Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.
Timothy R Baffi, An-Angela N Van, Wei Zhao, Gordon B Mills, Alexandra C Newton. Mol Cell 2019
27
100

Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity.
Chan Woo Kim, Daisuke Asai, Jeong-Hun Kang, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama. Tumour Biol 2016
15
100

Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors.
Wishrawana S Ratnayake, Christopher A Apostolatos, André H Apostolatos, Ryan J Schutte, Monica A Huynh, David A Ostrov, Mildred Acevedo-Duncan. Cell Adh Migr 2018
11
100

TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells.
Hassan Lemjabbar-Alaoui, Sukhvinder S Sidhu, Aklilu Mengistab, Marianne Gallup, Carol Basbaum. PLoS One 2011
39
100

Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.
Alessio Paone, Donatella Starace, Roberta Galli, Fabrizio Padula, Paola De Cesaris, Antonio Filippini, Elio Ziparo, Anna Riccioli. Carcinogenesis 2008
137
100

Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
Shusuke Akamatsu, Takahiro Inoue, Osamu Ogawa, Martin E Gleave. Int J Urol 2018
78
100

Protein kinase C (PKC) isozyme-specific substrates and their design.
Jeong-Hun Kang, Riki Toita, Chan Woo Kim, Yoshiki Katayama. Biotechnol Adv 2012
49
100

Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy.
Jinhui Wang, Weiyang Jin, Xiaoxin Zhou, Jiaqi Li, Chengdong Xu, Zhongjun Ma, Jianan Wang, Lele Qin, Biao Zhou, Wanjing Ding,[...]. J Med Chem 2020
7
100


Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins.
Federica Frezzato, Benedetta Accordi, Valentina Trimarco, Cristina Gattazzo, Veronica Martini, Gloria Milani, Silvia Bresolin, Filippo Severin, Andrea Visentin, Giuseppe Basso,[...]. J Leukoc Biol 2016
10
100

Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS).
Alessandra Cappellini, Sara Mongiorgi, Carlo Finelli, Antonietta Fazio, Stefano Ratti, Maria Vittoria Marvi, Antonio Curti, Valentina Salvestrini, Andrea Pellagatti, Anna Maria Billi,[...]. FASEB J 2020
3
100

PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation.
T Jiffar, S Kurinna, G Suck, D Carlson-Bremer, M R Ricciardi, M Konopleva, M Andreeff, P P Ruvolo. Leukemia 2004
53
100

Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cε with Stat3 involve integration with ERK1/2.
Jordan Marshall Sand, Bilal Bin Hafeez, Moammir Hasan Aziz, Emily Marie Siebers, Nancy Ellen Dreckschmidt, Ajit Kumar Verma. Mol Carcinog 2012
4
100

Gallbladder cancer: Historical treatment and new management options.
Kenji Okumura, Shekhar Gogna, Mahir Gachabayov, Daniel Moritz Felsenreich, Matthew McGuirk, Aram Rojas, Luis Quintero, Ramanathan Seshadri, Katie Gu, Xiang Da Dong. World J Gastrointest Oncol 2021
4
100

PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6-P38 MAPK pathway.
Yang Cheng, Yun Zhu, Wanfu Xu, Jiajia Xu, Min Yang, Peiyu Chen, Junhong Zhao, Lanlan Geng, Sitang Gong. Mol Carcinog 2018
18
100

Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
Iñigo Espinosa, Javier Briones, Ramon Bordes, Salut Brunet, Rodrigo Martino, Ana Sureda, Jaime Prat, Jorge Sierra. Ann Hematol 2006
20
100

Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.
K S Hill, E Erdogan, A Khoor, M P Walsh, M Leitges, N R Murray, A P Fields. Oncogene 2014
38
100

Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
Yarí E Marín, Jin Namkoong, Karine Cohen-Solal, Seung-Shick Shin, Jeffrey J Martino, Masahiro Oka, Suzie Chen. Cell Signal 2006
65
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.